Description: Emily is the name under which HLL Lifecare Limited markets a LNG IUS in India. It consists of a M-shaped polyethylene frame with a steroid reservoir containing 52 mg levonorgestrel held within an inserter tube. Also marketed for treatment of heavy menstrual bleeding.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Intrauterine

Duration Type: Long-acting

Duration: 5 years

  • Single insertion

Dose: 20 µg per day

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Inactive material: silicone rubber, LDPE plastic frame

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: HLL Lifecare Limited, Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)

Project Phase: Limited Market Availability

Development Stage: Marketed

Began discovery in: 2006

Active Development: Yes

Status Details:
  • Approved in India in 2011
  • Introduced for use in 2012.
  • Being registered in several countries outside of India

Additional Information

  • Product website: http://www.emily.org.in/#about

  • Gopimohan R, et al. (2015) A clinical study assessing the efficacy of a new variant of the levonorgestrel intrauterine system for abnormal uterine bleeding. Int J Gynaecol Obstet. 129(2):114-7.

Vertical Tabs